NON-SMALL CELL LUNG CANCER STAGE IIIB

This adverse event was reported 49 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE IIIB:

# Drug Count
0 CISPLATIN 9
1 SIMVASTATIN 6
2 VINORELBINE 6
3 ATENOLOL 5
4 CERITINIB 5
5 EPHEDRINE HYDROCHLORIDE 5
6 NICOTINE POLACRILEX 5
7 VALPROATE SODIUM 5
8 ASPIRIN 4
9 ASPIRIN 325 MG 4
See all common drugs associated with NON-SMALL CELL LUNG CANCER STAGE IIIB

NON-SMALL CELL LUNG CANCER STAGE IIIB is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPHEDRINE HYDROCHLORIDE 5 0.0110
1 CERITINIB 5 0.0021
2 FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID 1 0.0016
3 VINORELBINE 6 0.0009
4 NISOLDIPINE 1 0.0008
5 SAXAGLIPTIN 1 0.0007
6 SULINDAC 1 0.0004
7 FAMOTITINE 1 0.0003
8 VALPROATE SODIUM 5 0.0002
9 GEFITINIB 2 0.0002
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER STAGE IIIB

NON-SMALL CELL LUNG CANCER STAGE IIIB is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinergic Nicotinic Agonist [EPC] 5 0.0001
1 Provitamin D2 Compound [EPC] 2 0.0001
2 Vitamin D3 Analog [EPC] 1 0.0000
3 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
4 Aluminum Complex [EPC] 1 0.0000
5 Folate Analog [EPC] 2 0.0000
6 Vitamin A [EPC] 2 0.0000
7 Alkaloid [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 10 0.0000
9 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with NON-SMALL CELL LUNG CANCER STAGE IIIB